Does atorvastatin work more effectively than biguanides in reducing cardiovascular risk factors?
Increased risk of coronary artery disease in diabetic persons is associated with increased level of lipoproteins. Usually, such risks are reverted with glycemic control by antidiabetic medicines in Type I diabetes millitus. However, in Type II diabetes mellitus lipid values can be improved using ant...
Saved in:
Main Authors: | Afshan Siddiq (Author), Rafeeq Alam Khan (Author), Sadia Ghousia Baig (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
To study the effect of 'Isabgol' on absorption of 'Aspirin'
by: Muhammad Shahid, et al.
Published: (2010) -
Mechanisms of NMDA Receptor Inhibition by Biguanide Compounds
by: Arseniy S. Zhigulin, et al.
Published: (2024) -
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin
by: Delphine Laustriat, et al.
Published: (2015) -
Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes
by: Nicoll J, et al.
Published: (2020) -
Back to basics with active lifestyles: exercise is more effective than metformin to reduce cardiovascular risk in older adults with type 2 diabetes
by: Liliana C. Baptista, et al.
Published: (2018)